.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Congrats! I was able to add some @ .81 today, so the shares I got @ 1.18 a few days ago don't look too bad anymore. :)
GLTA!
Wow, sure didn't expect that...
GLTA!
Liz Claiborne Inc. to Release Third Quarter 2009 Results on Wednesday, November 4, 2009 -- http://finance.yahoo.com/news/Liz-Claiborne-Inc-to-Release-prnews-1654260375.html?x=0&.v=1
GLTA.
iBOX Updated! If anything needs added, let me know!
GLTA!
I believe the A/S will be increased. Hopefully if there's some new deals with Ariston they'll PR it first -- they need to issue PRs more frequently, imo.
JMO.
GLTA!
iBOX Updated!
GLTA!
Up .25 so far... Let's see if we can close over $1 today...
GLTA!
Nice move today!
GLTA!
NITE on ask @ .87 and on bid @ .75
Lets get some news this week!
GLTA!
Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles -- http://www.reuters.com/article/pressRelease/idUS181717+09-Oct-2009+PRN20091009
LOL. Hasn't it had only one green day since the Phase 2 results? I've never seen a stock sell off this much on news, BDSI wasn't this bad...
Any thoughts on where the bottom is?
Nice move today!
GLTA!
MHAN looking pretty good today... Let's break .10 by EOW.
JMO.
GLTA.
A little less than a month till the shareholders meeting -- anyone here going to be there?
GLTA!
Level 2 Details:
NITE on bid @ .085
UBSS and NITE on ask @ .09
GLTA.
IMHO, it's just profit taking from those who bought in sub-.20
If a company is on the OTC:BB, aren't they required to file SEC forms before they can dilute? I think I read that somewhere, but not sure if it's 100% accurate or not.
GLTA.
Wow, I haven't looked at this one much since it was hanging around .40-.50! Great buy, btw!
GLTA!
Thanks! :) I'm in the North Providence area...
Looks like MSBT has some profit taking going on today, makes for a good adding opportunity, IMHO.
GLTA!
DARA BioSciences Regains NASDAQ Compliance -- http://finance.yahoo.com/news/DARA-BioSciences-Regains-pz-3265243547.html?x=0&.v=1
Thanks for the update!
GLTA!!
Let's break .50 by EOD!
JMO!
GLTA!
Don't know if anyone has seen this but: http://clinicaltrials.gov/ct2/show/NCT00977171?term=Chelsea+Therapeutics&rank=6
If Droxidopa appears to benefit CFS patients, this stock could be a lot bigger than people think, imo.
JMO.
GLTA!
I think it will... Any news will make this stock go up, imo.
JMO.
GLTA!
What price do you think we'll see if they get FDA Approval?
GLTA!
LOL.
GLTY!
If results are positive, this will go way over $1, imo.
JMO.
GLTA!
Ask up to .36! Let's go for .50 by EOW!
GLTA!
Edit: Ask back down to .349.
Looking good today... Once they complete a trial for Hedrin, this stock will go crazy if the results are positive, imo.
GLTA!
10/8/2009 - Liz Claiborne Inc. Unveils Major New Distribution Strategy for the Liz Claiborne Brand Franchise -- http://finance.yahoo.com/news/Liz-Claiborne-Inc-Unveils-prnews-1614711391.html?x=0&.v=1
Great news last week!
GLTA!
Hmm... Interesting... What do you think NVD could go to if they license the approved products?
GLTA.
IMO, people are just finding out about this stock...
JMO.
GLTA.
Wow the Bid and Ask are spread far apart, imo... Tight float on this one...
GLTA.
Looks promising....
GLTA.
There is no SpoofEm app for the iPhone that I can find on iTunes...
It's not $heff's fault that PDMI is down today. It's been up all week, it's time for some profit taking, imo.
JMO.
GLTA!
It has been green the past few days, so some selling is not all that bad. IMO, people are mainly waiting on news here...
JMO.
GLTA!
Wow. Thanks... Have they started the 510k study yet? Or waiting until next year?
TIA.
From an SEC Form 10-K. Filed March 27, 2009:
In addition to the CEA and ACS Phase II clinical trials, the Company is currently conducting a third Phase II clinical trial involving VIA-2291 that utilizes FDG-PET to measure the impact of VIA-2291 on reducing vascular inflammation in treated patients. The Company plans to enroll approximately 50 patients following an acute coronary syndrome event, such as heart attack or stroke, into the 24 week, randomized, double blind, placebo-controlled study. Endpoints in the study include reduction in plaque inflammation as measured with FDG-PET, as well as assessment of standard biomarker measurements of inflammation. The FDG-PET clinical trial is expected to be completed and data reported in the second half of 2009.
Link: http://www.sec.gov/Archives/edgar/data/1003929/000095013409006232/f51890e10vk.htm
Top of page 8.
BTW, doesn't VIA have to find a way to pay Bay City Capital by 10/31? Once they release some news on how they're going to accomplish that, it could go over $1 imo. Especially if it's partnership news... VIAP reminds me of OPXA when they were trading .40-.50, and partnership news shot OPXA over $2.
JMO.
GLTA!